An increasing number of studies have showed that various immune checkpoint receptors, such as PD-1, CTLA4, TIGIT, TIM3, LAG3, and inflammatory factors, are expressed and altered in the tumor microenvironment. This evidence concerns the gene LAG3 and neoplasm.